搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
药品
/
rigl
/
财务摘要
Rigel Pharmaceuticals Inc
RIGL
添加自选
47.890
USD
-0.240
-0.50%
收盘 09-24 16:00(美东)
885.97M
总市值
2.37
市盈率 TTM
Rigel Pharmaceuticals Inc
47.890
-0.240
-0.50%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
RIGL 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Rigel Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
885.97M
股息TTM
0.00
市盈率 TTM
2.37
每股收益TTM
20.23
营业收入
294.28M
净利润
17.48M
净资产收益率
174.08%
总资产收益率
107.04%
Rigel Pharmaceuticals Inc 财报日历
最新发布
8月 4, 2026
每股收益 / 预测值
0.93
/0.62
营业收入 / 预测值
78.70M
/69.46M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-72.02%
0.93
-26.87%
0.47
1711.34%
14.72
119.16%
1.55
5779.21%
3.33
236.55%
0.64
1821.06%
0.81
316.22%
0.71
84.55%
-0.06
39.65%
-0.47
-57.70%
0.04
--
-0.33
--
-0.38
--
-0.78
--
0.10
--
-3.48
--
--
--
--
--
--
--
--
营业收入
-22.60%
78.70M
10.28%
58.82M
21.19%
69.80M
25.59%
69.46M
176.01%
101.69M
80.58%
53.33M
60.92%
57.60M
96.58%
55.31M
37.03%
36.84M
13.29%
29.53M
-30.20%
35.79M
25.54%
28.13M
-9.84%
26.89M
55.78%
26.07M
151.25%
51.28M
4.02%
22.41M
13.53%
29.82M
-79.34%
16.73M
10.62%
20.41M
17.15%
21.54M
净利润
-71.00%
17.29M
-24.39%
8.65M
1769.22%
268.06M
124.62%
27.90M
5887.67%
59.61M
238.79%
11.45M
1845.86%
14.34M
318.22%
12.42M
84.39%
-1.03M
39.07%
-8.25M
-47.39%
737.00K
70.10%
-5.69M
51.08%
-6.60M
50.68%
-13.54M
106.19%
1.40M
9.14%
-19.04M
2.38%
-13.49M
-169.48%
-27.45M
-17.70%
-22.64M
-47.82%
-20.95M
利润率
-62.53%
21.97%
-31.44%
14.71%
1442.36%
384.04%
78.85%
40.17%
2196.90%
58.63%
176.86%
21.46%
1109.22%
24.90%
211.01%
22.46%
88.61%
-2.80%
46.22%
-27.92%
-24.63%
2.06%
--
-20.23%
--
-24.55%
--
-51.92%
--
2.73%
--
-86.96%
--
--
--
--
--
--
--
--
毛利率
-6.70%
89.17%
0.48%
92.17%
1.69%
91.47%
8.97%
93.16%
3.45%
95.57%
-1.51%
91.73%
0.60%
89.95%
-10.48%
85.49%
-3.77%
92.38%
-3.23%
93.14%
-9.99%
89.41%
--
95.49%
--
96.00%
--
96.25%
--
99.33%
--
97.96%
--
--
--
--
--
--
--
--
资产负债率
-73.97%
7.53%
-73.82%
8.89%
-72.02%
10.18%
-42.55%
24.63%
-37.76%
28.93%
-28.04%
33.95%
-28.42%
36.40%
-17.14%
42.87%
-8.63%
46.49%
-1.96%
47.18%
73.07%
50.84%
--
51.73%
--
50.88%
--
48.12%
--
29.38%
--
34.14%
--
--
--
--
--
--
--
--
利润表
营业收入
-22.60%
78.70M
10.28%
58.82M
21.19%
69.80M
25.59%
69.46M
176.01%
101.69M
80.58%
53.33M
60.92%
57.60M
96.58%
55.31M
37.03%
36.84M
13.29%
29.53M
-30.20%
35.79M
25.54%
28.13M
-9.84%
26.89M
55.78%
26.07M
151.25%
51.28M
4.02%
22.41M
13.53%
29.82M
-79.34%
16.73M
10.62%
20.41M
17.15%
21.54M
营业利润
-61.42%
23.57M
-6.95%
11.88M
39.12%
23.17M
102.19%
28.42M
13569.57%
61.10M
283.36%
12.77M
747.15%
16.66M
414.80%
14.06M
108.49%
447.00K
45.26%
-6.97M
-42.16%
1.97M
75.74%
-4.46M
59.38%
-5.27M
51.54%
-12.72M
118.99%
3.40M
6.99%
-18.40M
0.64%
-12.96M
-162.89%
-26.26M
4.94%
-17.90M
-43.57%
-19.79M
净利润
-71.00%
17.29M
-24.39%
8.65M
1769.22%
268.06M
124.62%
27.90M
5887.67%
59.61M
238.79%
11.45M
1845.86%
14.34M
318.22%
12.42M
84.39%
-1.03M
39.07%
-8.25M
-47.39%
737.00K
70.10%
-5.69M
51.08%
-6.60M
50.68%
-13.54M
106.19%
1.40M
9.14%
-19.04M
2.38%
-13.49M
-169.48%
-27.45M
-17.70%
-22.64M
-47.82%
-20.95M
资产负债表
流动资产
5.78%
185.53M
59.68%
234.03M
77.77%
240.17M
101.87%
214.93M
85.16%
175.39M
58.47%
146.56M
36.10%
135.10M
12.04%
106.47M
-6.15%
94.72M
-13.54%
92.49M
-14.35%
99.27M
-13.96%
95.02M
-16.26%
100.92M
-23.01%
106.97M
-24.97%
115.90M
-35.45%
110.44M
-34.57%
120.52M
-29.39%
138.94M
73.59%
154.47M
71.36%
171.10M
流动负债总额
10.33%
95.59M
34.31%
89.49M
56.77%
99.24M
73.81%
94.40M
47.72%
86.64M
-8.97%
66.63M
18.83%
63.30M
12.51%
54.31M
33.22%
58.65M
60.81%
73.20M
-18.32%
53.27M
2.13%
48.27M
-19.89%
44.02M
-23.14%
45.52M
2.61%
65.21M
-20.27%
47.27M
-7.71%
54.95M
13.85%
59.23M
55.61%
63.55M
73.38%
59.28M
总资产
152.04%
521.07M
186.75%
504.61M
213.21%
513.59M
73.96%
242.53M
61.00%
206.74M
39.09%
175.97M
39.88%
163.98M
20.89%
139.42M
9.67%
128.41M
2.35%
126.52M
-12.70%
117.22M
-0.25%
115.32M
-8.52%
117.09M
-17.08%
123.61M
-19.75%
134.28M
-38.02%
115.61M
-36.51%
128.00M
-30.98%
149.07M
51.60%
167.33M
51.57%
186.52M
总负债
-23.36%
95.64M
-33.48%
104.71M
-24.01%
122.11M
-18.91%
124.92M
-21.17%
124.80M
-0.50%
157.41M
10.16%
160.69M
4.69%
154.06M
9.03%
158.32M
6.98%
158.19M
-1.37%
145.87M
8.65%
147.16M
10.27%
145.21M
3.93%
147.87M
7.99%
147.90M
-1.03%
135.44M
-1.36%
131.68M
3.33%
142.28M
79.37%
136.95M
89.80%
136.85M
总权益
419.23%
425.42M
2053.81%
399.90M
11806.33%
391.48M
903.56%
117.61M
373.90%
81.93M
158.62%
18.57M
111.48%
3.29M
54.02%
-14.64M
-6.40%
-29.91M
-30.56%
-31.67M
-110.37%
-28.64M
-60.50%
-31.83M
-664.62%
-28.11M
-456.83%
-24.26M
-144.83%
-13.62M
-139.93%
-19.83M
-105.40%
-3.68M
-91.32%
6.80M
-10.73%
30.37M
-2.52%
49.67M
现金流量表
经营净额
0.38%
30.65M
405.15%
2.73M
51.55%
21.98M
10.85%
24.03M
10011.59%
30.54M
82.19%
-893.00K
332.42%
14.50M
1695.22%
21.68M
-94.91%
302.00K
-23.05%
-5.01M
71.52%
-6.24M
89.78%
-1.36M
145.93%
5.93M
84.11%
-4.07M
-14.79%
-21.91M
-29.17%
-13.30M
-123.38%
-12.91M
-28.47%
-25.64M
-22.57%
-19.09M
47.15%
-10.30M
投资净额
174.98%
17.45M
24.42%
-7.97M
-132.38%
-25.36M
-972.57%
-33.17M
-312.97%
-23.28M
-3471.25%
-10.55M
-58.77%
-10.91M
424.96%
3.80M
267.98%
10.93M
-59.72%
313.00K
-136.96%
-6.87M
-111.19%
-1.17M
-85.92%
2.97M
-96.57%
777.00K
186.65%
18.60M
123.55%
10.46M
142.48%
21.09M
200.44%
22.63M
-25.52%
6.49M
-327.35%
-44.40M
融资净额
-2899.28%
-11.70M
-2355.99%
-10.92M
-412.08%
-4.57M
143.40%
4.27M
155.59%
418.00K
119.27%
484.00K
201.44%
1.47M
-1032.57%
-9.84M
-101.61%
-752.00K
-113.14%
-2.51M
123.19%
486.00K
-115.77%
-869.00K
93.41%
-373.00K
117.38%
19.12M
-293.18%
-2.10M
1911.31%
5.51M
-109.56%
-5.66M
319.50%
8.80M
62.67%
1.08M
426.92%
274.00K
常见问题
Rigel Pharmaceuticals Inc的总收入是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,总收入达到了294.28M(同比变化179.28M)。
Rigel Pharmaceuticals Inc的流动资产是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,流动资产为240.17M(同比变化77.77)。
Rigel Pharmaceuticals Inc的总资产是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,Rigel Pharmaceuticals Inc的总资产为513.59M(同比变化213.21)。
Rigel Pharmaceuticals Inc的总负债是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,Rigel Pharmaceuticals Inc的总负债为122.11M(同比变化-24.01)。
Rigel Pharmaceuticals Inc的总权益是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,Rigel Pharmaceuticals Inc的总权益为391.48M(同比变化11806.33)。
Rigel Pharmaceuticals Inc的净营业收入是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,Rigel Pharmaceuticals Inc的净营业收入为125.47M(同比变化418.63)。
Rigel Pharmaceuticals Inc的净投资是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,Rigel Pharmaceuticals Inc的净投资为-92.36M(同比变化-2336.44)。
Rigel Pharmaceuticals Inc的净融资是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,Rigel Pharmaceuticals Inc的净融资为601.00K(同比变化105.16)。
Rigel Pharmaceuticals Inc的每股收益(EPS)是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为20.40(同比变化1951.47)。
Rigel Pharmaceuticals Inc的净利润是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,净利润为367.02M(同比变化1999.08)。
Rigel Pharmaceuticals Inc的净利润率是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,净利润率为124.72(同比变化1178.77)。
Rigel Pharmaceuticals Inc的毛利率是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,毛利率为93.33(同比变化4.17)。
Rigel Pharmaceuticals Inc的债务与资产比率是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,债务与资产比率为10.18(同比变化-72.02)。
Rigel Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为108.34(同比变化771.15)。
Rigel Pharmaceuticals Inc的营业利润是多少?
根据Rigel Pharmaceuticals Inc的FY2025财报,营业利润为125.47M(同比变化418.63)。